David Morgenstern

Title: David Morgenstern: Innovator in Antibody Detection

Introduction

David Morgenstern is an accomplished inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biotechnology, particularly in the detection of antibodies. With a total of 2 patents to his name, Morgenstern's work has the potential to impact medical diagnostics and research.

Latest Patents

Morgenstern's latest patents focus on the detection of anti-p53 antibodies. The first patent describes an in vitro method for detecting an antibody to p53 (anti-p53 antibody) in a sample. This method involves incubating a sample with a p53 capture antigen and a p53 detection antigen. A complex is formed that includes the p53 capture antigen, the anti-p53 antibody, and the p53 detection antigen. The complex is then separated from unbound detection antigen, and the measurement of the complex is conducted via the detection antigen, allowing for the detection of the anti-p53 antibody in the sample.

Career Highlights

Throughout his career, Morgenstern has worked with notable companies in the biotechnology sector, including Roche Diagnostics Operations, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in antibody detection and diagnostics.

Collaborations

Morgenstern has collaborated with several professionals in his field, including Herbert Andres and Johann Karl. These collaborations have likely enriched his research and development efforts.

Conclusion

David Morgenstern is a notable inventor whose work in antibody detection has the potential to advance medical diagnostics. His contributions to the field are marked by his innovative patents and collaborations with industry professionals.